Advisory: Incorrect alerts related to Straton Therapeutics withdrawn
12/06/2023 22:08
Alerts on Straton Therapeutics receiving authorization from FDA
for its multiple myeloma trial had several errors and have been
withdrawn.
For the correct set of alerts, click: urn:newsml:reuters.com:*:nFWN3841WJ
STORY_NUMBER: TUAB4LS1X
STORY_DATE: 12/06/2023
STORY_TIME: 08:30:01
((bangalore.newsroom@thomsonreuters.com))
Recent news on Healthwell Acquisition I
See all newsBrief: Healthwell Acquisition Corp. I Announces Cancellation Of Special Stockholder Meeting And Its Intention To Liquidate
Brief: Healthwell Acquisition Announces Termination Of Business Combination With Starton Therapeutics
Brief: Healthwell Acquisition Corp. I Announces Postponement Of The Special Meeting Of Stockholders To Approve The Proposed Business Combination With Starton Therapeutics And Related Transactions
Brief: FDA Authorizes Starton Therapeutics To Proceed With Star-LLD Lenalidomide Phase 1b Clinical Trial
Advisory: Incorrect alerts related to Straton Therapeutics withdrawn